SHL Telemedicine Ltd American Depositary Shares - Asset Resilience Ratio
SHL Telemedicine Ltd American Depositary Shares (SHLT) has an Asset Resilience Ratio of 12.19% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SHL Telemedicine Ltd American Depositary (SHLT) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2024)
This chart shows how SHL Telemedicine Ltd American Depositary Shares's Asset Resilience Ratio has changed over time. See net assets of SHL Telemedicine Ltd American Depositary for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down SHL Telemedicine Ltd American Depositary Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SHL Telemedicine Ltd American Depositary stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $9.84 Million | 12.19% |
| Total Liquid Assets | $9.84 Million | 12.19% |
Asset Resilience Insights
- Moderate Liquidity: SHL Telemedicine Ltd American Depositary Shares has 12.19% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
SHL Telemedicine Ltd American Depositary Shares Industry Peers by Asset Resilience Ratio
Compare SHL Telemedicine Ltd American Depositary Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcidion Group Ltd
AU:ALC |
Health Information Services | 32.45% |
|
DocCheck AG
XETRA:AJ91 |
Health Information Services | 6.71% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
Oneview Healthcare Plc
AU:ONE |
Health Information Services | 29.71% |
|
Singular Health Group Ltd
AU:SHG |
Health Information Services | 0.15% |
Annual Asset Resilience Ratio for SHL Telemedicine Ltd American Depositary Shares (2005–2024)
The table below shows the annual Asset Resilience Ratio data for SHL Telemedicine Ltd American Depositary Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 12.19% | $9.84 Million | $80.76 Million | -5.11pp |
| 2023-12-31 | 17.30% | $19.56 Million | $113.05 Million | +4.47pp |
| 2022-12-31 | 12.83% | $14.22 Million | $110.78 Million | -0.45pp |
| 2021-12-31 | 13.29% | $17.22 Million | $129.59 Million | +3.29pp |
| 2020-12-31 | 10.00% | $6.48 Million | $64.81 Million | +2.04pp |
| 2018-12-31 | 7.96% | $4.42 Million | $55.53 Million | +0.77pp |
| 2017-12-31 | 7.19% | $4.71 Million | $65.50 Million | -0.27pp |
| 2016-12-31 | 7.46% | $4.67 Million | $62.63 Million | +1.35pp |
| 2015-12-31 | 6.11% | $4.55 Million | $74.45 Million | -9.43pp |
| 2014-12-31 | 15.54% | $14.32 Million | $92.13 Million | -2.58pp |
| 2013-12-31 | 18.12% | $19.66 Million | $108.52 Million | +1.92pp |
| 2012-12-31 | 16.20% | $16.16 Million | $99.73 Million | +1.06pp |
| 2011-12-31 | 15.14% | $16.38 Million | $108.20 Million | -3.38pp |
| 2010-12-31 | 18.52% | $17.60 Million | $95.06 Million | +16.33pp |
| 2006-12-31 | 2.19% | $2.80 Million | $128.32 Million | +4.60pp |
| 2005-12-31 | -2.41% | $-3.31 Million | $137.38 Million | -- |
About SHL Telemedicine Ltd American Depositary Shares
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company als… Read more